AMGEN INC (1AMGN.MI) Fundamental Analysis & Valuation

BIT:1AMGN • US0311621009

Current stock price

329.15 EUR
+14.1 (+4.48%)
Last:

This 1AMGN.MI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

8

1. 1AMGN.MI Profitability Analysis

1.1 Basic Checks

  • In the past year 1AMGN was profitable.
  • In the past year 1AMGN had a positive cash flow from operations.
  • 1AMGN had positive earnings in each of the past 5 years.
  • Each year in the past 5 years 1AMGN had a positive operating cash flow.
1AMGN.MI Yearly Net Income VS EBIT VS OCF VS FCF1AMGN.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B

1.2 Ratios

  • Looking at the Return On Assets, with a value of 8.51%, 1AMGN is in the better half of the industry, outperforming 79.52% of the companies in the same industry.
  • With an excellent Return On Equity value of 89.06%, 1AMGN belongs to the best of the industry, outperforming 98.80% of the companies in the same industry.
  • 1AMGN's Return On Invested Capital of 16.85% is amongst the best of the industry. 1AMGN outperforms 93.98% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for 1AMGN is above the industry average of 12.00%.
  • The 3 year average ROIC (14.35%) for 1AMGN is below the current ROIC(16.85%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 8.51%
ROE 89.06%
ROIC 16.85%
ROA(3y)6.63%
ROA(5y)7.92%
ROE(3y)88.81%
ROE(5y)106.67%
ROIC(3y)14.35%
ROIC(5y)15.45%
1AMGN.MI Yearly ROA, ROE, ROIC1AMGN.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50 100 150

1.3 Margins

  • The Profit Margin of 1AMGN (20.98%) is better than 79.52% of its industry peers.
  • 1AMGN's Profit Margin has declined in the last couple of years.
  • The Operating Margin of 1AMGN (34.19%) is better than 85.54% of its industry peers.
  • 1AMGN's Operating Margin has improved in the last couple of years.
  • 1AMGN has a Gross Margin of 73.30%. This is in the better half of the industry: 1AMGN outperforms 60.24% of its industry peers.
  • 1AMGN's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 34.19%
PM (TTM) 20.98%
GM 73.3%
OM growth 3Y4.6%
OM growth 5Y4.15%
PM growth 3Y-5.54%
PM growth 5Y-5.99%
GM growth 3Y2.93%
GM growth 5Y1.72%
1AMGN.MI Yearly Profit, Operating, Gross Margins1AMGN.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. 1AMGN.MI Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so 1AMGN is creating value.
  • 1AMGN has more shares outstanding than it did 1 year ago.
  • The number of shares outstanding for 1AMGN has been reduced compared to 5 years ago.
  • Compared to 1 year ago, 1AMGN has an improved debt to assets ratio.
1AMGN.MI Yearly Shares Outstanding1AMGN.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M
1AMGN.MI Yearly Total Debt VS Total Assets1AMGN.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B 80B

2.2 Solvency

  • The Debt to FCF ratio of 1AMGN is 6.74, which is on the high side as it means it would take 1AMGN, 6.74 years of fcf income to pay off all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 6.74, 1AMGN is in the better half of the industry, outperforming 77.11% of the companies in the same industry.
  • A Debt/Equity ratio of 5.78 is on the high side and indicates that 1AMGN has dependencies on debt financing.
  • 1AMGN's Debt to Equity ratio of 5.78 is on the low side compared to the rest of the industry. 1AMGN is outperformed by 68.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 5.78
Debt/FCF 6.74
Altman-Z N/A
ROIC/WACC1.95
WACC8.66%
1AMGN.MI Yearly LT Debt VS Equity VS FCF1AMGN.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B

2.3 Liquidity

  • 1AMGN has a Current Ratio of 1.14. This is a normal value and indicates that 1AMGN is financially healthy and should not expect problems in meeting its short term obligations.
  • The Current ratio of 1AMGN (1.14) is worse than 66.27% of its industry peers.
  • A Quick Ratio of 0.90 indicates that 1AMGN may have some problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 0.90, 1AMGN is doing worse than 67.47% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.14
Quick Ratio 0.9
1AMGN.MI Yearly Current Assets VS Current Liabilites1AMGN.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B 40B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. 1AMGN.MI Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an nice 10.24% over the past year.
  • 1AMGN shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 5.65% yearly.
  • 1AMGN shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 9.95%.
  • 1AMGN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.65% yearly.
EPS 1Y (TTM)10.24%
EPS 3Y7.29%
EPS 5Y5.65%
EPS Q2Q%-0.38%
Revenue 1Y (TTM)9.95%
Revenue growth 3Y11.77%
Revenue growth 5Y7.65%
Sales Q2Q%8.58%

3.2 Future

  • 1AMGN is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 4.03% yearly.
  • 1AMGN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.56% yearly.
EPS Next Y3.12%
EPS Next 2Y3.35%
EPS Next 3Y2.5%
EPS Next 5Y4.03%
Revenue Next Year2.04%
Revenue Next 2Y2.46%
Revenue Next 3Y1.68%
Revenue Next 5Y2.56%

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
1AMGN.MI Yearly Revenue VS Estimates1AMGN.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 10B 20B 30B 40B
1AMGN.MI Yearly EPS VS Estimates1AMGN.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 10 20 30

More info and screens

Find the best growth stocksShow best growing peers

5

4. 1AMGN.MI Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 17.40, 1AMGN is valued on the expensive side.
  • Compared to the rest of the industry, the Price/Earnings ratio of 1AMGN indicates a rather cheap valuation: 1AMGN is cheaper than 86.75% of the companies listed in the same industry.
  • The average S&P500 Price/Earnings ratio is at 27.42. 1AMGN is valued slightly cheaper when compared to this.
  • The Price/Forward Earnings ratio is 16.87, which indicates a correct valuation of 1AMGN.
  • 1AMGN's Price/Forward Earnings ratio is rather cheap when compared to the industry. 1AMGN is cheaper than 89.16% of the companies in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 22.24. 1AMGN is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 17.4
Fwd PE 16.87
1AMGN.MI Price Earnings VS Forward Price Earnings1AMGN.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of 1AMGN indicates a rather cheap valuation: 1AMGN is cheaper than 81.93% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 25.27
EV/EBITDA N/A
1AMGN.MI Per share data1AMGN.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40 -40

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates 1AMGN does not grow enough to justify the current Price/Earnings ratio.
  • The excellent profitability rating of 1AMGN may justify a higher PE ratio.
PEG (NY)5.57
PEG (5Y)3.08
EPS Next 2Y3.35%
EPS Next 3Y2.5%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

6

5. 1AMGN.MI Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 2.74%, 1AMGN has a reasonable but not impressive dividend return.
  • 1AMGN's Dividend Yield is rather good when compared to the industry average which is at 0.63. 1AMGN pays more dividend than 93.98% of the companies in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.81, 1AMGN pays a better dividend.
Industry RankSector Rank
Dividend Yield 2.74%

5.2 History

  • The dividend of 1AMGN is nicely growing with an annual growth rate of 9.41%!
Dividend Growth(5Y)9.41%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

  • 1AMGN's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP0%
EPS Next 2Y3.35%
EPS Next 3Y2.5%
1AMGN.MI Yearly Income VS Free CF VS Dividend1AMGN.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

More info and screens

Find the best dividend stocksShow peers with best dividend

1AMGN.MI Fundamentals: All Metrics, Ratios and Statistics

AMGEN INC

BIT:1AMGN (3/2/2026, 7:00:00 PM)

329.15

+14.1 (+4.48%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)02-03
Earnings (Next)04-29
Inst Owners85.05%
Inst Owner ChangeN/A
Ins Owners0.06%
Ins Owner ChangeN/A
Market Cap177.43B
Revenue(TTM)36.75B
Net Income(TTM)7.71B
Analysts70.95
Price Target301.84 (-8.3%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.74%
Yearly Dividend7.85
Dividend Growth(5Y)9.41%
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)9.92%
Min EPS beat(2)9.56%
Max EPS beat(2)10.28%
EPS beat(4)4
Avg EPS beat(4)10.8%
Min EPS beat(4)9.56%
Max EPS beat(4)11.73%
EPS beat(8)7
Avg EPS beat(8)6.29%
EPS beat(12)11
Avg EPS beat(12)5.41%
EPS beat(16)14
Avg EPS beat(16)4.51%
Revenue beat(2)2
Avg Revenue beat(2)3.3%
Min Revenue beat(2)2.11%
Max Revenue beat(2)4.49%
Revenue beat(4)3
Avg Revenue beat(4)1.61%
Min Revenue beat(4)-0.84%
Max Revenue beat(4)4.49%
Revenue beat(8)4
Avg Revenue beat(8)0.19%
Revenue beat(12)5
Avg Revenue beat(12)-0.22%
Revenue beat(16)6
Avg Revenue beat(16)-0.27%
PT rev (1m)0%
PT rev (3m)1.85%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0.48%
EPS NY rev (1m)0%
EPS NY rev (3m)2.41%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.2%
Revenue NY rev (1m)0%
Revenue NY rev (3m)2.09%
Valuation
Industry RankSector Rank
PE 17.4
Fwd PE 16.87
P/S 5.57
P/FCF 25.27
P/OCF 20.55
P/B 23.64
P/tB N/A
EV/EBITDA N/A
EPS(TTM)18.92
EY5.75%
EPS(NY)19.51
Fwd EY5.93%
FCF(TTM)13.03
FCFY3.96%
OCF(TTM)16.02
OCFY4.87%
SpS59.11
BVpS13.92
TBVpS-51.94
PEG (NY)5.57
PEG (5Y)3.08
Graham Number76.9912 (-76.61%)
Profitability
Industry RankSector Rank
ROA 8.51%
ROE 89.06%
ROCE 19.3%
ROIC 16.85%
ROICexc 19.6%
ROICexgc 73.08%
OM 34.19%
PM (TTM) 20.98%
GM 73.3%
FCFM 22.04%
ROA(3y)6.63%
ROA(5y)7.92%
ROE(3y)88.81%
ROE(5y)106.67%
ROIC(3y)14.35%
ROIC(5y)15.45%
ROICexc(3y)16.88%
ROICexc(5y)18.44%
ROICexgc(3y)72.7%
ROICexgc(5y)79.08%
ROCE(3y)16.43%
ROCE(5y)17.69%
ROICexgc growth 3Y-3.21%
ROICexgc growth 5Y2.03%
ROICexc growth 3Y4.63%
ROICexc growth 5Y5.17%
OM growth 3Y4.6%
OM growth 5Y4.15%
PM growth 3Y-5.54%
PM growth 5Y-5.99%
GM growth 3Y2.93%
GM growth 5Y1.72%
F-Score7
Asset Turnover0.41
Health
Industry RankSector Rank
Debt/Equity 5.78
Debt/FCF 6.74
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 5.06%
Interest Coverage 250
Cash Conversion N/A
Profit Quality 105.05%
Current Ratio 1.14
Quick Ratio 0.9
Altman-Z N/A
F-Score7
WACC8.66%
ROIC/WACC1.95
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)4.09%
Cap/Sales(5y)3.84%
Profit Quality(3y)156.25%
Profit Quality(5y)149.01%
High Growth Momentum
Growth
EPS 1Y (TTM)10.24%
EPS 3Y7.29%
EPS 5Y5.65%
EPS Q2Q%-0.38%
EPS Next Y3.12%
EPS Next 2Y3.35%
EPS Next 3Y2.5%
EPS Next 5Y4.03%
Revenue 1Y (TTM)9.95%
Revenue growth 3Y11.77%
Revenue growth 5Y7.65%
Sales Q2Q%8.58%
Revenue Next Year2.04%
Revenue Next 2Y2.46%
Revenue Next 3Y1.68%
Revenue Next 5Y2.56%
EBIT growth 1Y73.11%
EBIT growth 3Y16.9%
EBIT growth 5Y12.12%
EBIT Next Year31.54%
EBIT Next 3Y9.81%
EBIT Next 5Y8.24%
FCF growth 1Y-22.07%
FCF growth 3Y-2.67%
FCF growth 5Y-3.91%
OCF growth 1Y-13.33%
OCF growth 3Y0.81%
OCF growth 5Y-1.05%

AMGEN INC / 1AMGN.MI Fundamental Analysis FAQ

What is the ChartMill fundamental rating of AMGEN INC (1AMGN.MI) stock?

ChartMill assigns a fundamental rating of 5 / 10 to 1AMGN.MI.


What is the valuation status of AMGEN INC (1AMGN.MI) stock?

ChartMill assigns a valuation rating of 5 / 10 to AMGEN INC (1AMGN.MI). This can be considered as Fairly Valued.


Can you provide the profitability details for AMGEN INC?

AMGEN INC (1AMGN.MI) has a profitability rating of 8 / 10.


What is the financial health of AMGEN INC (1AMGN.MI) stock?

The financial health rating of AMGEN INC (1AMGN.MI) is 3 / 10.


What is the expected EPS growth for AMGEN INC (1AMGN.MI) stock?

The Earnings per Share (EPS) of AMGEN INC (1AMGN.MI) is expected to grow by 3.12% in the next year.